Top news
What India's COVID-19 crisis means for Africa | Brookings
Two doses of Pfizer, AstraZeneca shots effective against Delta variant: study
By barbara lewis & Alistair Smout
If you got the Johnson & Johnson vaccine, do you need another dose?
By Jane Weaver & Akshay Syal
All coverage
Biden administration buying more vaccine doses for kids and possible boosters
By Tim Perry & Kathryn Watson
South African firm to make Pfizer vaccine, first in Africa
By Carley Petesch & Andrew Meldrum
Pfizer-BioNTech to start producing Covid-19 vaccines in South Africa in 2022
By David McKenzie & Jeevan Ravindran
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggests (Published 2021)
By Apoorva Mandavilli
Israel says Pfizer Covid vaccine is just 39% effective as delta spreads, but still prevents severe illness
By Berkeley Lovelace & Berkeley Lovelace Jr.
J&J forecasts $2.5 bln in 2021 COVID-19 vaccine sales, sets lower production target
By Manas Mishra & Carl O'Donnell
South African firm to help make Pfizer/BioNTech COVID vaccine
By Michael Erman, Wendell Roelf & Alexander Winning